404 related articles for article (PubMed ID: 25764168)
21. [Cystic fibrosis lung disease and its management].
Hidaka N; Hidaka Y
Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
[TBL] [Abstract][Full Text] [Related]
22. Cystic fibrosis: therapies targeting specific gene defects.
Thursfield RM; Davies JC
Paediatr Respir Rev; 2012 Dec; 13(4):215-9. PubMed ID: 23069118
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy in cystic fibrosis.
Prickett M; Jain M
Transl Res; 2013 Apr; 161(4):255-64. PubMed ID: 23273902
[TBL] [Abstract][Full Text] [Related]
24. New and emerging therapies for pulmonary complications of cystic fibrosis.
Tonelli MR; Aitken ML
Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
[TBL] [Abstract][Full Text] [Related]
25. [On the way to gene therapy in cystic fibrosis].
Norek A; Bal J
Med Wieku Rozwoj; 2006; 10(1 Pt 2):247-74. PubMed ID: 17028392
[TBL] [Abstract][Full Text] [Related]
26. Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets.
Sun X; Olivier AK; Liang B; Yi Y; Sui H; Evans TI; Zhang Y; Zhou W; Tyler SR; Fisher JT; Keiser NW; Liu X; Yan Z; Song Y; Goeken JA; Kinyon JM; Fligg D; Wang X; Xie W; Lynch TJ; Kaminsky PM; Stewart ZA; Pope RM; Frana T; Meyerholz DK; Parekh K; Engelhardt JF
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):502-12. PubMed ID: 24074402
[TBL] [Abstract][Full Text] [Related]
27. The future of cystic fibrosis care: a global perspective.
Bell SC; Mall MA; Gutierrez H; Macek M; Madge S; Davies JC; Burgel PR; Tullis E; Castaños C; Castellani C; Byrnes CA; Cathcart F; Chotirmall SH; Cosgriff R; Eichler I; Fajac I; Goss CH; Drevinek P; Farrell PM; Gravelle AM; Havermans T; Mayer-Hamblett N; Kashirskaya N; Kerem E; Mathew JL; McKone EF; Naehrlich L; Nasr SZ; Oates GR; O'Neill C; Pypops U; Raraigh KS; Rowe SM; Southern KW; Sivam S; Stephenson AL; Zampoli M; Ratjen F
Lancet Respir Med; 2020 Jan; 8(1):65-124. PubMed ID: 31570318
[TBL] [Abstract][Full Text] [Related]
28. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
29. [Cystic fibrosis: molecular update and clinical implications].
Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
[TBL] [Abstract][Full Text] [Related]
30. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
Cantin AM; Hartl D; Konstan MW; Chmiel JF
J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in cystic fibrosis.
Milla CE; Moss RB
Curr Opin Pediatr; 2015 Jun; 27(3):317-24. PubMed ID: 25888148
[TBL] [Abstract][Full Text] [Related]
32. Rhinosinusitis in the pediatric patient with cystic fibrosis.
Fundakowski C; Ojo R; Younis R
Curr Pediatr Rev; 2014; 10(3):198-201. PubMed ID: 25088340
[TBL] [Abstract][Full Text] [Related]
33. Emerging pharmacotherapies in cystic fibrosis.
McElvaney OJ; Gunaratnam C; McElvaney OF; Bagwe I; Reeves EP; McElvaney NG
Expert Rev Respir Med; 2018 Oct; 12(10):843-855. PubMed ID: 30129380
[TBL] [Abstract][Full Text] [Related]
34. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life.
Cohen-Cymberknoh M; Shoseyov D; Kerem E
Am J Respir Crit Care Med; 2011 Jun; 183(11):1463-71. PubMed ID: 21330455
[TBL] [Abstract][Full Text] [Related]
35. Cystic Fibrosis and Its Management Through Established and Emerging Therapies.
Spielberg DR; Clancy JP
Annu Rev Genomics Hum Genet; 2016 Aug; 17():155-75. PubMed ID: 26905785
[TBL] [Abstract][Full Text] [Related]
36. Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out.
Parsons D; Donnelley M
Hum Gene Ther; 2020 Sep; 31(17-18):973-984. PubMed ID: 32718206
[TBL] [Abstract][Full Text] [Related]
37. Advances in the diagnosis and treatment of cystic fibrosis.
Martiniano SL; Hoppe JE; Sagel SD; Zemanick ET
Adv Pediatr; 2014 Aug; 61(1):225-43. PubMed ID: 25037130
[TBL] [Abstract][Full Text] [Related]
38. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
Wang Y; Wrennall JA; Cai Z; Li H; Sheppard DN
Int J Biochem Cell Biol; 2014 Jul; 52():47-57. PubMed ID: 24727426
[TBL] [Abstract][Full Text] [Related]
39. Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.
Torphy TJ; Allen J; Cantin AM; Konstan MW; Accurso FJ; Joseloff E; Ratjen FA; Chmiel JF;
Ann Am Thorac Soc; 2015 Sep; 12(9):1398-406. PubMed ID: 26146892
[TBL] [Abstract][Full Text] [Related]
40. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
